Dry Powder Inhaler Market Size, Share, Segments and Forecast, 2023 - 2032

According to the report published by Zion Market Research, the global Dry Powder Inhaler Market size was valued at USD 20.37 Billion in 2023 and is predicted to reach USD 27.92 Billion by the end of 2032. The market is expected to grow with a CAGR of 3.57% during the forecast period. The report analyzes the global Dry Powder Inhaler Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Dry Powder Inhaler Market industry.

Request Free Sample

Dry Powder Inhaler Market: Overview

Dry powder inhaler is a medical device that is used for the effective delivery of medication to the lungs. The medication comes in the form of dry powder. The patients who suffer from various respiratory diseases make use of the dry powder inhalers as they are portable and are easy to carry.

Dry Powder Inhaler Market: Facts

The market player Inspiro Medical has developed the product Inspiromatic™ which is an advanced version of the dry powder inhalers. The device has an active dry powder fluidization mechanism which works in the low inhalation flow rates.

Dry Powder Inhaler Market: Segmentation

The global market for the dry powder inhaler is fragmented into its product type, application, and end-user industry.

Based on the product type, the global market is segregated into multi-dose dry powder inhaler and single dose dry powder inhaler.

Based on the application, the market is categorized into COPD, cardiovascular diseases, asthma, diabetes, cystic fibrosis, and others.

Based on the end-user industry, the market is divided into home & personal care and clinics & hospitals.

Request Free Sample

Dry Powder Inhaler Market: Growth Factors

The patients that suffer from different types of respiratory diseases have a major concern regarding taking of accurate dosage of medicines. The factors that are contributing to the growth of the market are the rise in the number of the cases being registered of respiratory disease and the rise in the aging population increases the demand for the dry powder inhalers. The market players are trying to develop various innovations in the devices that are used for the inhalation purposes thus propelling the growth of the market.

The opportunities for the market are increasing as the manufacturers are trying to use new methods such as computational fluid dynamics for the development of the new generation products. The factors that are limiting the growth of the market are these devices are not resistant to moisture thus if the medicine comes in contact with moisture it loses its properties and the availability of the other competitive products in the market such as electric pumps and nebulizers.

Dry Powder Inhaler Market : Report Scope

Dry Powder Inhaler Market: Regional Analysis

The market for the dry powder inhaler is dominated by the North American region. The major factor that contributes to the market growth is the early adoption of the advanced medical technologies in this region. Europe is following the North American region and is expected to grow rapidly in the coming years owing to the presence of the major pharmaceutical companies in this region. There are huge investments made by the market players for the development of the healthcare sector in this region. In Asia Pacific region, the market will grow at a good speed owing to the increasing disposable income and the developing economy in the region. In Asia Pacific region, there is a significant growth in the geriatric population which is increasing the demand for the dry powder inhalers.

Dry Powder Inhaler Market: Competitive Players

The key market players that are involved in the dry powder inhaler market include:

• Cipla Inc.
• GlaxoSmithKline Plc.
• Teicos Pharma Ltd.
• Presspart Manufacturing Ltd.
• Beximco Pharma Ltd.
• Catalent, Inc.
• Hovione FarmaCiencia SA.
• AstraZeneca Plc.
• Bespak Europe Ltd.
• Luckys Pharma
• SRS Pharmaceuticals Pvt. Ltd.

The Global Dry Powder Inhaler Market is segmented as follows:

By Product type 

• multi-dose dry powder inhaler
• single dose dry powder inhaler 

By Application 

• COPD 
• cardiovascular diseases
• asthma, diabetes 
• cystic fibrosis 
• and others

By end-user industry 

• home & personal care 
• clinics & hospitals

Dry Powder Inhaler Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.